Navigation Links
European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012
Date:12/4/2011

d or refractory NHL and/or other tumors as determined by the FDA and/or the EMA, that CTI may not receive a positive opinion regarding approvability of pixantrone from the CHMP on January 19, 2012 or at all, that CTI may receive an additional list of outstanding issues from the EMA, that CTI may not be able to demonstrate the efficacy of pixantrone in patients previously exposed to rituximab as requested by the EMA, that CTI may not be able to provide satisfactory answers to the other concerns included in the CHMP's day-180 list of outstanding issues, that CTI may not be able to submit its response to the CHMP's day-180 list of outstanding issues by December 19, 2011, that the CHMP may request additional information from CTI regarding pixantrone, that CTI may not be able to commence commercialization of pixantrone in the first half 2012, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:
Dan Eramian
T: 206.272.4343
C: 206.854.1200
E: deramian@ctiseattle.com
www.CellTherapeutics.com/press_room

Investors Contact:
Ed Bell
T: 206.282.7100
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com 
www.CellTherapeutics.co
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CardioInsight Announces CE Mark Clearance and European Launch of the ECVUE™ Non-Invasive Electrocardiographic Mapping System
2. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
3. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
4. X-ray Equipment - Top 5 European Markets
5. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
6. RSB Spine, LLC, Announces European Patent Allowance
7. Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union
8. Amgen Statement on European Investor Visit
9. European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive)
10. Misonix Announces its Exhibition at the European Association of Neurosurgical Societies
11. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... to the NASDAQ Biotechnology Index (NBI). The addition ... upon market open on December 22, 2014. ... track the performance of a set of NASDAQ-listed ... pharmaceutical according to the Industry Classification Benchmark. The ...
(Date:12/15/2014)... , Dec. 15, 2014 As medical ... (Structured Product Labeling) markup language standard, content teams have ... and skills to work with the standard. Starting January ... of three webinars on the benefits and the critical ... webinars will be facilitated by Howard Shatz , ...
(Date:12/15/2014)... BOSTON , December 15, 2014 ... and development company, is pleased to announce the grant ... States relating to its GPCR-focused drug discovery ... significantly strengthens the global patent estate covering Heptares, technologies ... The suite of patents recently granted by the US ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2
... Cardinal Health plans to release first-quarter financial results for ... of trading on the New York Stock Exchange. ... Oct. 27 at 8:30 a.m. Eastern Daylight Time to discuss ... go to the Investors page at cardinalhealth.com/investors or dial 617.213.8835 ...
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced ... in the Biotech Industry conference on Friday, October 21 at ... ) A live audio webcast of the ... Company,s website at www.optimerpharma.com .  Replays of the presentation ...
Cached Medicine Technology:Cardinal Health to Release First-quarter Financial Results on Oct. 27 2
(Date:12/15/2014)... 15, 2014 Health Dialog, a ... today that it has received Patient Oriented Accreditation ... for its Disease Management (DM) Programs for asthma, ... coronary heart disease and diabetes. This marks the ... Health Dialog’s Disease Management (DM) Programs, reaffirming Health ...
(Date:12/15/2014)... Dallas,TX (PRWEB) December 15, 2014 The increase ... is one of the main factors which is contributing to ... used for the diagnosis and treatment of hearing loss and ... comprises of three parts - microphone, speaker and amplifier. The ... growth rate of 6.01% during the period from 2014 to ...
(Date:12/15/2014)... December 15, 2014 In support ... bring attention to restrictive state laws that may ... on this important area of public health policy. ... Compromise the Integrity of Independent Review, contends that ... of independent peer review determinations can result in ...
(Date:12/15/2014)... IL (PRWEB) December 15, 2014 Kenmode ... joined the firm as Director of Quality Assurance. ... managing quality systems, processes and certifications for manufacturers in ... the posts of Corporate Quality Manager at Sonoco Products ... Quality at NetCom, Inc., and Quality Assurance Manager for ...
(Date:12/15/2014)... December 15, 2014 Following on the ... The Grass Station is gearing up for another round ... Colorado’s oldest and largest marijuana dispensaries, began the 2014 ... that ran through Thanksgiving weekend. , “We've picked ... are excited,” says Grass Station CEO and founder, Ryan ...
Breaking Medicine News(10 mins):Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2Health News:Colorado’s Grass Station Helps Holiday Shoppers Put Something Special under the Christmas Tree 2
... Call Today at 5 p.m. Eastern Time -, ... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... progress and financial results,for the third quarter ended ... continued to make important progress in,developing picoplatin as ...
... 30 Physicians Healthcare,Management Group, Inc. (Phyhealth) (Pink ... in partnership with physicians,today announced that it has ... 30, 2008. The financials are being posted today ... its updated financials, Phyhealth expects to,qualify for the ...
... liver failure deaths, other risks of adverse events for ... -- The diabetes drug Avandia should be banned in ... liver failure and poses many other life-threatening risks that ... said Thursday. , The group said it has identified ...
... it,s not clear if the cholesterol-lowering drugs protect against ... A new study shows that men who take cholesterol-lowering ... antigen (PSA), a biomarker for prostate cancer risk. , ... drugs protect against disease however, researchers say. , But ...
... American Society of Nephrology (ASN) proudly announce the recipient ... was created to provide funding for young faculty to ... transition funding toward successful application for an RO1 grant. ... Torban, Assistant Professor in the Department of Medicine, Division ...
... Free antibiotic and pre-natal vitamin programs help millions of Meijer ... ... Oct. 30 Grand Rapids-based retailer,Meijer received the Legacy of Leadership ... The award was presented,during the 29th Annual Distinguished Service Awards luncheon ...
Cached Medicine News:Health News:Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update 2Health News:Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update 3Health News:Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update 4Health News:Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update 5Health News:Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update 6Health News:Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update 7Health News:Phyhealth Issues 2008 Third Quarter Financial Statements 2Health News:Consumer Group Seeks FDA Ban on Avandia 2Health News:Consumer Group Seeks FDA Ban on Avandia 3Health News:Statins Lower Blood Marker for Prostate Cancer 2Health News:Halpin Foundation and the ASN announce recipient of Halpin Foundation-ASN research grant 2Health News:Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents 2Health News:Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents 3
... connection of two state-of-the-art progressive scan digital ... beamsplitter on your microscope. The c-mount digital ... firewire cards and receive their power directly ... optical visualization without interference or compromise. The ...
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
... monitoring of oxygen and carbon dioxide, originally ... in a number of different applications, including ... medicine and orthopedic surgery. TcpO2 measurements usually ... to provide a good picture. The more ...
Derrico Perforator Drill and Enlarging Burr...
Medicine Products: